Clinical Research
More than 5 years of experience in BE development services, has passed the inspections of the National Medical Products Administration (NMPA), European Medicines Agency (EMA), and U.S. Food and Drug Administration (FDA), with integrated solutions.
• CRO service
• Analysis of biological samples
• Data management and statistical analysis
Compound | Calibration Range |
---|---|
Clarithromycin | 2.5-2500 ng/mL;2-2000 ng/mL |
Diclofenac | 10-5000 ng/mL |
Fexofenadine | 1-500 ng/mL |
Desloratadine | 25-5000 pg/mL;25-2500 pg/mL |
Azithromycin | 0.5-500 ng/mL |
Trimebutine | 1-250 ng/mL |
Levetiracetam | 0.25-25 μg/mL |
Voriconazole | 10-5000 ng/mL |
Oxcarbazepine | 4-2000 ng/mL;20-10000 ng/mL |
Linezolid | 0.025-25.0 μg/mL |
Allopurinol | 5-3000 ng/mL |
Rupatadine | 0.05-10.0 ng/mL |
Oseltamivir | 0.5-300 ng/mL;2-1000 ng/mL |
Carbamazepine | 50-7000 ng/mL |
Topiramate | 50-7000 ng/mL |
Bilastine | 2-600 ng/mL |
Memantine | 0.5-100 ng/mL |
Mexiletine | 2-1000 ng/mL |
•Hangzhou Kangbai Hospital (close strategic cooperation);
•Zhejiang Xiaoshan Hospital (close strategic cooperation);
• Zibo Central Hospital (close strategic cooperation);
•Haikou People's Hospital (close strategic cooperation);
•Hengyang Huacheng Hospital (strategic cooperation);
• The Second Affiliated Hospital of South China University (strategic cooperation);
• Zhejiang Provincial People's Hospital, the First Hospital of Jilin University; Shanghai Xuhui District Central Hospital...
• Dose climbing tolerance test
• Multiple doses
• Food effects
• Drug interactions
•Clinical phase II
•Clinical phase III